RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-small Cell Lung Cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34301751/

doi: 10.1158/1078-0432.CCR-21-0273. Online ahead of print. 1 Department of Medical Oncology, Kindai University [email protected]. 2 Department of Medical Oncology, Catalan Institute of Oncology. 3 Medicine, Hematology/Oncology, David Geffen School of Medicine at UCLA. 4 Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation For Cancer Research.